Opis Europe European Clinical Cro

  • Home Cover
Opis is an European clinical cro and it is the best solution for your trials

Clinical CRO - full service

Who We Are

OPIS was founded in 1998 as a small Italian CRO. Over the past 20 years we have worked with passion and dedication to conquer the trust of clients and the scientific community, learning from each project and challenge convinced that investing in knowledge earns the highest interest. Today, OPIS is the number one Italian CRO, with more than 240 employees at headquarters. At international level, OPIS manages both local and international full-service studies thanks to its offices located throughout Europe.

From its beginning, OPIS has managed complex and demanding projects in terms of study rationale and design, treatment features and patient characteristics. With time, this has led to the advancement of our main strengths: helping clients single out the best solution by putting forward positive and interesting proposals, flexibility, responsiveness, qualified personnel, cohesive and organized teams, and sustained monitoring of project status. OPIS has always been driven by a passion for research, a thirst for knowledge, and the desire to offer a personalized service that meets client needs without ever breaching the ethical and legal requirements that govern the conduct of clinical studies.



Services

Clinical Research Solutions

Expertise

Oncology Oncology
Hematology Hematology
Cardiovascular Diseases Cardiovascular Diseases
Neurology Neurology
Respiratory Diseases Respiratory Diseases
Rheumatology Rheumatology
Immunology and Transplantation Immunology and Transplantation
Metabolism and Nutritional Disorders Metabolism and Nutritional Disorders
Ophthalmology Ophthalmology

In 20 years of combining medical, regulatory, statistical and technological expertise, OPIS has assisted over 40 different clients with interventional and non-interventional clinical trials. Full service projects in a wide range of therapeutic areas include various rare disease indications as well as pediatric studies. Currently, over 40% of trials managed by OPIS are oncology or onco-hematology trials. Other major therapeutic areas include ophthalmology, neurology and cardiology. OPIS has established collaboration with numerous international Sponsors on multi-country trials. In addition to phase I-IV drug-related trials, OPIS also holds experience in managing clinical investigations for medical and diagnostic devices and in nutraceutical/food supplement studies.


News

Blog
Blog
Blog